Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Dulai Biotechnology is a Chinese life sciences company specializing in the distribution and manufacturing of biochemical reagents and laboratory consumables. Based in Nanjing, the company provides a comprehensive portfolio of over 10,000 products, including enzyme preparations, high-purity proteins, antibiotics, culture media, and molecular biology reagents. It serves a diverse clientele across pharmaceutical research, biopharmaceutical manufacturing, food science, and cosmetics industries. Established in 2014, the company has built a reputation for its extensive supply chain and quality management systems, facilitating both domestic sales and international exports. Its catalog prominently features separation materials like Sephadex and agarose gels, as well as specialty enzymes for analytical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Dulai Biotechnology.